Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 119

    1.

    Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells.

    You F, Roberts LA, Kang SP, Nunes RA, Dias C, Iglehart JD, Solomon NA, Friedman PN, Harris LN.

    J Hematol Oncol. 2008 May 28;1:2.

    PMID:
    18577250
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.

    Nunes RA, Li X, Kang SP, Burstein H, Roberts L, Carney W, Blackwell K, Ryan P, Borges V, Iglehart JD, Friedman P, Harris LN.

    Int J Biol Markers. 2009 Jan-Mar;24(1):1-10.

    PMID:
    19404916
    [PubMed - indexed for MEDLINE]
    3.

    [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].

    Ke F, Wu JM, Yao JE, Bai YJ, Guo AL.

    Zhonghua Yi Xue Za Zhi. 2007 Aug 28;87(32):2257-61. Chinese.

    PMID:
    18001545
    [PubMed - indexed for MEDLINE]
    4.

    Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.

    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.

    Hepatogastroenterology. 2008 May-Jun;55(84):1131-5.

    PMID:
    18705345
    [PubMed - indexed for MEDLINE]
    5.

    Molecular signature detection of circulating tumor cells using a panel of selected genes.

    Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.

    Cancer Lett. 2008 May 18;263(2):267-79. Epub 2008 Feb 8.

    PMID:
    18262345
    [PubMed - indexed for MEDLINE]
    6.

    Detection of circulating tumor cells in metastatic breast cancer patients.

    Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S.

    Endocr Regul. 2011 Jul;45(3):113-24.

    PMID:
    21793623
    [PubMed - indexed for MEDLINE]
    7.

    Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.

    Schröder CP, Ruiters MH, de Jong S, Tiebosch AT, Wesseling J, Veenstra R, de Vries J, Hoekstra HJ, de Leij LF, de Vries EG.

    Int J Cancer. 2003 Sep 10;106(4):611-8.

    PMID:
    12845661
    [PubMed - indexed for MEDLINE]
    8.

    Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.

    Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D.

    Clin Cancer Res. 2008 May 1;14(9):2593-600.

    PMID:
    18451221
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.

    Wang L, Wang Y, Liu Y, Cheng M, Wu X, Wei H.

    J Exp Clin Cancer Res. 2009 Apr 28;28:57.

    PMID:
    19397830
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.

    Marrakchi R, Ouerhani S, Benammar S, Rouissi K, Bouhaha R, Bougatef K, Messai Y, Khadimallah I, Rahal K, Ben Ammar-Elgaaied A.

    Int J Biol Markers. 2008 Oct-Dec;23(4):238-43.

    PMID:
    19199272
    [PubMed - indexed for MEDLINE]
    11.

    [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].

    Zheng HY, Chen Q, Ye YB, Huang WW.

    Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2267-70. Chinese.

    PMID:
    19087676
    [PubMed - indexed for MEDLINE]
    12.

    Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.

    Chen CC, Hou MF, Wang JY, Chang TW, Lai DY, Chen YF, Hung SY, Lin SR.

    Cancer Lett. 2006 Aug 28;240(2):279-88. Epub 2005 Nov 11.

    PMID:
    16289546
    [PubMed - indexed for MEDLINE]
    13.

    Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.

    Breast Cancer Res Treat. 2009 Oct;117(3):525-34. Epub 2008 Nov 19. Erratum in: Breast Cancer Res Treat. 2009 Oct;117(3):539.

    PMID:
    19016323
    [PubMed - indexed for MEDLINE]
    14.

    [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].

    López Guerrero JA, Bolufer P, Barragán E, Sanz Alonso M, Palau J, Sempere A, De la Rubia J, Bonanad S, Torregrosa MD.

    Sangre (Barc). 1996 Dec;41(6):441-6. Spanish.

    PMID:
    9148421
    [PubMed - indexed for MEDLINE]
    15.

    Her2/neu expression by reverse transcriptase-polymerase chain reaction in the peripheral blood of prostate cancer patients.

    Fantinato AP, Tobias-Machado M, Fonseca F, Pinto JL, Wroclawski ML, Wroclawski E, Verotti M, del Giglio A.

    Tumori. 2007 Sep-Oct;93(5):467-72.

    PMID:
    18038879
    [PubMed - indexed for MEDLINE]
    16.

    Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells.

    Lambrechts AC, Bosma AJ, Klaver SG, Top B, Perebolte L, van' t Veer LJ, Rodenhuis S.

    Breast Cancer Res Treat. 1999 Aug;56(3):219-31.

    PMID:
    10573113
    [PubMed - indexed for MEDLINE]
    17.

    Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

    Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, Cappadona S, Biganzoli L, Giannini A, Di Leo A.

    Breast Cancer Res Treat. 2009 Dec;118(3):523-30. Epub 2009 Jul 12.

    PMID:
    19597704
    [PubMed - indexed for MEDLINE]
    18.

    Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.

    Fabisiewicz A, Kulik J, Kober P, Brewczyńska E, Pieńkowski T, Siedlecki JA.

    Acta Biochim Pol. 2004;51(3):747-55.

    PMID:
    15448736
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.

    J Clin Oncol. 2007 Nov 20;25(33):5194-202. Epub 2007 Oct 22.

    PMID:
    17954712
    [PubMed - indexed for MEDLINE]
    20.

    Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

    Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P, Snijders PJ, Meijer CJ.

    Int J Cancer. 2008 Jun 1;122(11):2562-7.

    PMID:
    18324628
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk